Middle East and Africa Remote Cardiac Monitoring Market Trends and Analysis by 2028

The remote cardiac monitoring market in MEA is expected to grow from US$ 146.35 million in 2021 to US$ 909.86 million by 2028; it is estimated to grow at a CAGR of 29.8% from 2021 to 2028.

The UAE, Saudi Arabia, and South Africa are major economies in MEA. Surge in incidence of cardiovascular diseases is the major factor driving the growth of the MEA remote cardiac monitoring market. Remote patient monitoring (RPM) allows patients to manage their health better by increasing their involvement in their health care. RPM may serve as a vital conduit for improving hypertension control and reducing the economic burden stemming from prolonged or frequent hospital stays that result from acute hypertension-related events. Research has shown that RPM can significantly lower systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to usual care and self-monitoring alone. According to a few non-randomized trials, RPM can improve outcomes by enabling accurate and early detection as well as decreasing all-cause mortality rates and hospitalizations. Recent clinical guidelines strongly recommend the use of RPM for atrial fibrillation (AF) detection in both stroke and non-stroke patients, which is further anticipated to drive the Remote Cardiac Monitoring market in MEA.

The COVID-19 pandemic has increased the demand for medical devices, which can be used in-home care. The region is witnessing an increase in the number of patients admitted to intensive care units (ICU). An increasing number of drugs pose multiple diagnostic and therapeutic challenges to strained health systems, leading to an increase in medical devices. Radiologists in South Africa have the highest number of COVID-19 infections in the country. There are changes in staff assignments, working hours, strict infection control, and social distancing measures. They also face mental, physical, emotional, and financial challenges.Heart patients, especially those with implantable devices for heart-failure treatment, are at increased risk of COVID-19 morbidity and mortality. In addition, there is growing evidence that COVID-19 has significant and long-term effects on the heart that can lead to an echo pandemic of patients with heart failure. Remote and biosensor device surveillance were quickly introduced during the COVID-19 pandemic to allow better assessment of the clinical status of the heart while maintaining social distance by conducting virtual visits. With the ever-increasing costs associated with health care enrollment and the imposition of social distancing, finding solutions to better monitor heart disease is imperative. For this reason, several new devices have emerged in recently.

 

MEA Remote Cardiac Monitoring Market Segmentation  

MEA Remote Cardiac Monitoring Market – By Product Type

• Devices
  • Vital Signs Monitors
  • Heart Rate Monitors
  • Blood Pressure Monitors
  • Breath Monitors
  • Holter Monitors
  • Others
• Software
  • Cloud Based Software
  • On-Premise Software
• Services

MEA Remote Cardiac Monitoring Market – By End User

• Hospitals and Clinics
• Emergency Settings
• Homecare Settings
• Others

MEA Remote Cardiac Monitoring Market– By Country

• Saudi Arabia
• South Africa
• UAE
• RoMEA

MEA Remote Cardiac Monitoring Market-Companies Mentioned

• Abbott
• Boston Scientific Corporation
• GE Healthcare
• Honeywell International Inc.
• Koninklijke Philips N.V.
• Medtronic
• Nihon Kohden Corporation
• OSI Systems, Inc.

Middle East and Africa Remote Cardiac Monitoring Report Scope